关注
John Schmitz
John Schmitz
在 som.umaryland.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Thymidylate synthase inhibitors as anticancer agents: from bench to bedside
E Chu, MA Callender, MP Farrell, JC Schmitz
Cancer chemotherapy and pharmacology 52, 80-89, 2003
2322003
Thymidylate synthase: a critical target for cancer chemotherapy
MG Rose, MP Farrell, JC Schmitz
Clinical colorectal cancer 1 (4), 220-229, 2002
1852002
Thymidylate synthase as a translational regulator of cellular gene expression
J Liu, JC Schmitz, X Lin, N Tai, W Yan, M Farrell, M Bailly, T Chen, E Chu
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587 (2-3 …, 2002
1632002
The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer
C Chung, CC Mader, JC Schmitz, J Atladottir, P Fitchev, ML Cornwell, ...
Laboratory investigation 91 (5), 732-743, 2011
1432011
Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis
H Liu, JC Schmitz, J Wei, S Cao, JH Beumer, S Strychor, L Cheng, M Liu, ...
Oncology research 21 (5), 247, 2014
1422014
Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administrated orally and intravenously
DG Priest, JC Schmitz, MA Bunni, RK Stuart
Oxford University Press 83 (24), 1806-1812, 1991
1031991
Short interfering RNA–mediated gene silencing of vascular endothelial growth factor: Effects on cellular proliferation in colon cancer cells
AL Mulkeen, T Silva, PS Yoo, JC Schmitz, E Uchio, E Chu, C Cha
Archives of Surgery 141 (4), 367-374, 2006
922006
Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
N Wei, J Li, C Fang, J Chang, V Xirou, NK Syrigos, BJ Marks, E Chu, ...
Oncogene 38 (10), 1676-1687, 2019
832019
Protein kinase d as a potential chemotherapeutic target for colorectal cancer
N Wei, E Chu, P Wipf, JC Schmitz
Molecular cancer therapeutics 13 (5), 1130-1141, 2014
762014
Impact of dietary folic acid on reduced folates in mouse plasma and tissues: relationship to dideazatetrahydrofolate sensitivity
JC Schmitz, GB Grlndey, RM Schultz, DG Priest
Biochemical pharmacology 48 (2), 319-325, 1994
661994
Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells
J Ju, JC Schmitz, B Song, K Kudo, E Chu
Clinical cancer research 13 (14), 4245-4251, 2007
642007
Translational autoregulation of thymidylate synthase and dihydrofolate reductase
N Tai, JC Schmitz, J Liu, X Lin, M Bailly, TM Chen, E Chu
Front Biosci 9, 2521-2526, 2004
642004
Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds
JC Schmitz, T Chen, E Chu
Cancer research 64 (4), 1431-1435, 2004
492004
Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer
Y Xi, G Nakajima, JC Schmitz, E Chu, J Ju
BMC genomics 7, 1-15, 2006
482006
Effect of 2′-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells
JC Schmitz, D Yu, S Agrawal, E Chu
Nucleic Acids Research 29 (2), 415-422, 2001
482001
Total Synthesis of (−)-CP2-Disorazole C1
CD Hopkins, JC Schmitz, E Chu, P Wipf
Organic letters 13 (15), 4088-4091, 2011
452011
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas
LB Jilaveanu, CR Zito, SA Aziz, PJ Conrad, JC Schmitz, M Sznol, ...
Clinical Cancer Research 15 (18), 5704-5713, 2009
442009
Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition
N Tai, Y Ding, JC Schmitz, E Chu
Nucleic acids research 30 (20), 4481-4488, 2002
402002
Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway
H Liu, H Liu, Z Zhou, RA Parise, E Chu, JC Schmitz
Cell Communication and Signaling 16, 1-12, 2018
332018
Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer
AA Tarhini, H Zahoor, B Mclaughlin, WE Gooding, JC Schmitz, ...
Anticancer research 33 (10), 4475-4481, 2013
332013
系统目前无法执行此操作,请稍后再试。
文章 1–20